Australia’s National Digital Health Strategy: Key Implications for the Pharmaceutical & Medical Technology Sector
How Pharma and Medtech Industries Have Opportunities to Innovate to Align With New Digital Health Standards
In this article we discuss highlights and key implications of the National Digital Health Strategy 2023-24 for the pharma and medtech sectors, including opportunities for innovation in remote monitoring, data analytics and digital therapeutics, as well as challenges in regulatory compliance and cybersecurity.
